Inventor

DORNER FRIEDRICH

AT92 patents

⚠️ This page may combine multiple inventors who share the name “DORNER FRIEDRICH”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

DORNER FRIEDRICH

BAXTER AG

Recombinant cell clones having increased stability and methods of making and using the same

Recombinant cell clones having increased stability and methods of making and using the same

Influenza virus vaccine composition

Recombinant cell clones having increased stability and methods of making and using the same

Factor IX/factor IXa activating antibodies and antibody derivatives

Stable factor VIII/von Willebrand factor complex

Production of orthomyxoviruses in monkey kidney cells using protein-free media

Expression plasmid, a fusion protein, a transfected eukaryotic cell line, a method of producing foreign proteins, a foreign protein preparation as well as a pharmaceutical composition

Nucleic acids encoding factor X analogues having a modified protease cleavage site

Nucleic acids encoding factor X deletion mutants and analogues thereof

Method of recovering highly purified vWF or factor VIII/vWF-complex

Factor X analogues with a modified protease cleavage site

Factor X deletion mutants and analogues thereof

Purification of von-Willebrand factor by cation exchanger chromatography

Direct molecular cloning of foreign genes into poxviruses and methods for the preparation of recombinant proteins

Vaccine for the prevention of lyme disease

Fusion protein comprising a furin derivative or a derivative of a furin analogue and a heterologous sequence

Process for disintegrating nucleic acids and preparing biological products of guaranteed quality

Method of inactivating lipid-enveloped viruses

Methods for generating immune responses employing modified vaccinia of fowlpox viruses

Method for isolation of highly pure von willebrand factor

IMMUNO AG

Recombinant cell clone having increased stability in serum- and protein-free medium and a method of recovering the stable cell clone and the production of recombinant proteins by using a stable cell clone

Recombinant poxviruses with foreign DNA in essential regions

Method for producing viruses and vaccines in serum-free culture

High and low molecular weight fractions of von Willebrand Factor and preparations of same

Method for isolation of highly pure von Willebrand Factor

Method of inactivating reproducible filterable pathogens in blood products as well as a method of producing blood products

recombinant poxviruses with foreign DNA in essential regions

Recombinant fowlpox virus

Method for the isolation and purification of vitamin K-dependent proteins

Preparation active against Pseudomonas aeruginosa infections and methods of producing them

Preparations active against pseudomonas aeruginosa infections and methods of producing them

Method for isolation of highly pure von willebrand factor

Method for virus inactivation in the presence of polyalkylene glycol as well as the pharmaceutical preparation obtained therewith

Method for controlling the infectivity of viruses

Avian embryo cell aggregate biomass for producing virus/virus antigen and method for producing virus/virus antigen

Method for the purification of PC protein from Borrelia burgdorferi

Method of inactivating reproducible filterable pathogens in blood plasma products

Method of quantitating genomic DNA

Method of quantitating nucleic acid

Direct molecular cloning of a modified poxvirus genome

BAXTER HEALTHCARE SA

Inactivated influenza virus vaccine for nasal or oral application

Inactivated influenza virus vaccine for nasal or oral application

BAXALTA INC

Animal protein-free media for cultivation of cells

Animal protein-free media for cultivation of cells

BAXTER VACCINE AG

Immunogenic formulation of OspC antigen vaccines for the prevention and treatment of lyme disease and recombinant methods for the preparation of such antigens

Immunogenic formulation of OSPC antigen vaccines for the prevention and treatment of lyme disease and recombinant methods for the preparation of such antigens

BAXTER INNOVATIONS GMBH

Medium for the protein-free and serum-free cultivation of cells

BIO PROD & BIO ENG AG

Method for the separation of recombinant pro-factor IX from recombinant factor IX

SANDOZ AG

Process for producing a structurally modified interferon